These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32192808)

  • 1. [Hereditary predisposition to tumors of the central and peripheral nervous systems].
    Sourty B; Rousseau A
    Ann Pathol; 2020 Apr; 40(2):168-179. PubMed ID: 32192808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumors of central and peripheral nervous system associated with inherited genetic syndromes.
    Stefanaki K; Alexiou GA; Stefanaki C; Prodromou N
    Pediatr Neurosurg; 2012; 48(5):271-85. PubMed ID: 23796843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nervous system (NS) Tumors in Cancer Predisposition Syndromes.
    Patil P; Pencheva BB; Patil VM; Fangusaro J
    Neurotherapeutics; 2022 Oct; 19(6):1752-1771. PubMed ID: 36056180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the management of familial central nervous system tumor syndromes.
    Hottinger AF; Khakoo Y
    Curr Neurol Neurosci Rep; 2007 May; 7(3):200-7. PubMed ID: 17488585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular genetics of familial tumour syndromes of the central nervous system].
    Murnyák B; Szepesi R; Hortobágyi T
    Orv Hetil; 2015 Feb; 156(5):171-7. PubMed ID: 25618858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurooncology of familial cancer syndromes.
    Hottinger AF; Khakoo Y
    J Child Neurol; 2009 Dec; 24(12):1526-35. PubMed ID: 19955345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hereditary tumor syndromes in neuropathology].
    Mawrin C
    Pathologe; 2017 May; 38(3):186-196. PubMed ID: 28474160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis.
    Sigauke E; Rakheja D; Maddox DL; Hladik CL; White CL; Timmons CF; Raisanen J
    Mod Pathol; 2006 May; 19(5):717-25. PubMed ID: 16528370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes.
    Farrell CJ; Plotkin SR
    Neurol Clin; 2007 Nov; 25(4):925-46, viii. PubMed ID: 17964021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of diagnostic neuropathology in familial tumour syndromes].
    Feiden S; Sartorius E; Feiden W
    Pathologe; 2010 Oct; 31(6):464-70. PubMed ID: 20848106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in brain tumor predisposing syndromes.
    Johansson G; Andersson U; Melin B
    Acta Oncol; 2016; 55(4):401-11. PubMed ID: 26634384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Syndromes: Neurosurgical Evaluation and Management.
    Ganapathy A; Diaz EJ; Coleman JT; Mackey KA
    Neurosurg Clin N Am; 2022 Jan; 33(1):91-104. PubMed ID: 34801146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic insights into familial tumors of the nervous system.
    Melean G; Sestini R; Ammannati F; Papi L
    Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):74-84. PubMed ID: 15264275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome.
    Hasselblatt M; Thomas C; Federico A; Nemes K; Johann PD; Bison B; Bens S; Dahlum S; Kordes U; Redlich A; Lessel L; Pajtler KW; Mawrin C; Schüller U; Nolte K; Kramm CM; Hinz F; Sahm F; Giannini C; Penkert J; Kratz CP; Pfister SM; Siebert R; Paulus W; Kool M; Frühwald MC
    Am J Surg Pathol; 2022 Sep; 46(9):1277-1283. PubMed ID: 35446794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?
    Rizzo D; Fréneaux P; Brisse H; Louvrier C; Lequin D; Nicolas A; Ranchère D; Verkarre V; Jouvet A; Dufour C; Edan C; Stéphan JL; Orbach D; Sarnacki S; Pierron G; Parfait B; Peuchmaur M; Delattre O; Bourdeaut F
    Am J Surg Pathol; 2012 Jul; 36(7):964-72. PubMed ID: 22614000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
    Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
    JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
    Kley N; Whaley J; Seizinger BR
    Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdoid tumor predisposition syndrome.
    Sredni ST; Tomita T
    Pediatr Dev Pathol; 2015; 18(1):49-58. PubMed ID: 25494491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
    Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
    Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on Cancer Predisposition Syndromes and Surveillance Guidelines for Childhood Brain Tumors.
    Hansford JR; Das A; McGee RB; Nakano Y; Brzezinski J; Scollon SR; Rednam SP; Schienda J; Michaeli O; Kim SY; Greer MC; Weksberg R; Stewart DR; Foulkes WD; Tabori U; Pajtler KW; Pfister SM; Brodeur GM; Kamihara J
    Clin Cancer Res; 2024 Jun; 30(11):2342-2350. PubMed ID: 38573059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.